Search
for
Sort by
Research 661–690 of 1000+
- Presumptive Albendazole Toxicosis in 12 Alpacas
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Association of Spironolactone Use With Risk of Cancer
- The Pressurized Skin: A Review on the Pathological Effect of Mechanical Pressure on the Skin from the Cellular Perspective
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Alopecia areata – Current understanding and management
- Epidemiology of Vitiligo – A Dual Population-Based Approach
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Pectin Nanoparticle-Loaded Soft Coral Nephthea sp. Extract as In Situ Gel Enhances Chronic Wound Healing: In Vitro, In Vivo, and In Silico Studies
- Use of topical clascoterone for the treatment of hidradenitis suppurativa
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Human iPS Cell-Derived Cell Aggregates Exhibited Dermal Papilla Cell Properties in in vitro Three-Dimensional Assemblage Mimicking Hair Follicle Structures
- ‘Dr. Google, What Is That on My Skin?’—Internet Searches Related to Skin Problems: Google Trends Data from 2004 to 2019
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives